1. Home
  2. QURE vs CASS Comparison

QURE vs CASS Comparison

Compare QURE & CASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • CASS
  • Stock Information
  • Founded
  • QURE 1998
  • CASS 1906
  • Country
  • QURE Netherlands
  • CASS United States
  • Employees
  • QURE N/A
  • CASS N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • CASS Business Services
  • Sector
  • QURE Health Care
  • CASS Consumer Discretionary
  • Exchange
  • QURE Nasdaq
  • CASS Nasdaq
  • Market Cap
  • QURE 691.2M
  • CASS 588.1M
  • IPO Year
  • QURE 2007
  • CASS 1996
  • Fundamental
  • Price
  • QURE $12.84
  • CASS $43.18
  • Analyst Decision
  • QURE Strong Buy
  • CASS Buy
  • Analyst Count
  • QURE 8
  • CASS 1
  • Target Price
  • QURE $39.43
  • CASS $45.00
  • AVG Volume (30 Days)
  • QURE 798.8K
  • CASS 43.1K
  • Earning Date
  • QURE 03-03-2025
  • CASS 04-17-2025
  • Dividend Yield
  • QURE N/A
  • CASS 2.86%
  • EPS Growth
  • QURE N/A
  • CASS N/A
  • EPS
  • QURE N/A
  • CASS 1.39
  • Revenue
  • QURE $28,587,000.00
  • CASS $219,894,000.00
  • Revenue This Year
  • QURE $153.92
  • CASS N/A
  • Revenue Next Year
  • QURE N/A
  • CASS $7.70
  • P/E Ratio
  • QURE N/A
  • CASS $31.22
  • Revenue Growth
  • QURE N/A
  • CASS 3.13
  • 52 Week Low
  • QURE $3.73
  • CASS $37.99
  • 52 Week High
  • QURE $19.18
  • CASS $49.16
  • Technical
  • Relative Strength Index (RSI)
  • QURE 38.20
  • CASS 51.44
  • Support Level
  • QURE $12.72
  • CASS $42.30
  • Resistance Level
  • QURE $14.42
  • CASS $45.45
  • Average True Range (ATR)
  • QURE 0.85
  • CASS 1.10
  • MACD
  • QURE -0.26
  • CASS 0.08
  • Stochastic Oscillator
  • QURE 7.26
  • CASS 55.84

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment.

Share on Social Networks: